Company intelligence / Profile preview

Resources of Cangzhou

Cangzhou, Hebei, China

Ownership: Private
Development stage: Other

Overview

Cangzhou Enke Pharma is a Chinese pharmaceutical company specializing in the research, development, and large-scale manufacturing of active pharmaceutical ingredients (APIs) and advanced intermediates. Located in the Cangzhou Lingang Economic and Technological Development Zone, the company focuses on high-quality chemical synthesis for global markets. Their product portfolio includes treatments for cardiovascular diseases, diabetes, and viral infections. Enke Pharma operates as a key supplier and contract manufacturing partner, leveraging modern GMP-compliant facilities to support international pharmaceutical supply chains.

Therapeutic areas: Infectious DiseasesCardiovascularEndocrinology
Modalities: Small molecule
Industry: Contract Manufacturing Organization

Beyond the preview

Go deeper on Resources of Cangzhou.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Resources of Cangzhou.

Explore the full profile